Skip to main content

Roche raises outlook for 2018 as new drugs gain traction

First-half sales and profit easily beat analyst expectations on the strength of newer drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.